Although prostate cancer is the most common cancer diagnosed in men, it has a relatively good prognosis when diagnosed and treated early. The purpose of this course is to educate healthcare professionals about the epidemiology, screening, diagnosis, and treatment of prostate cancer to ensure that the disease is diagnosed early and treated properly. In addition, members of the public may use this course to enhance their personal knowledge of the subject matter presented.
Upon completion of this course, you should be able to:
1. Review the epidemiology and demographics of prostate cancer.
2. Discuss what is known about the pathophysiology of prostate cancer.
3. Discuss the associated symptoms and diagnosis of prostate cancer.
4. State the current recommendations regarding prostate cancer screening.
5. Describe the potential role of diet in reducing prostate cancer risk.
6. Discuss the role of surgery and radiotherapy as treatments for prostate cancer.
7. Describe the role of androgen deprivation therapy for the treatment of prostate cancer.
8. Discuss the role of chemotherapy as a treatment for prostate cancer.
9. Analyze the research and use of 5-alpha reductase inhibitors as a treatment for prostate cancer.
10. Recommend interventions for men who have experienced erectile dysfunction or depression as a result of prostate cancer, including considerations for non-English-proficient patients.
This 5-hour continuing education course is available for download for professional development; if continuing education credit is desired, please see instructions included in eBook.
Upon completion of this course, you should be able to:
1. Review the epidemiology and demographics of prostate cancer.
2. Discuss what is known about the pathophysiology of prostate cancer.
3. Discuss the associated symptoms and diagnosis of prostate cancer.
4. State the current recommendations regarding prostate cancer screening.
5. Describe the potential role of diet in reducing prostate cancer risk.
6. Discuss the role of surgery and radiotherapy as treatments for prostate cancer.
7. Describe the role of androgen deprivation therapy for the treatment of prostate cancer.
8. Discuss the role of chemotherapy as a treatment for prostate cancer.
9. Analyze the research and use of 5-alpha reductase inhibitors as a treatment for prostate cancer.
10. Recommend interventions for men who have experienced erectile dysfunction or depression as a result of prostate cancer, including considerations for non-English-proficient patients.
This 5-hour continuing education course is available for download for professional development; if continuing education credit is desired, please see instructions included in eBook.
